<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02179450</url>
  </required_header>
  <id_info>
    <org_study_id>Cognition_Facial palsy</org_study_id>
    <nct_id>NCT02179450</nct_id>
  </id_info>
  <brief_title>Cognitive Function and Emotional Possessing in Bilateral Facial Palsy</brief_title>
  <official_title>Pilot Study Assessing Cognitive Function and Emotional Possessing in Patients With Bilateral Facial Palsy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kirsten Elwischger, MD</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Vienna</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Based on recent findings that botulinum toxin injections in the cranial muscles might reduce
      emotional processing (Havas 2011), an increasing number of popular newspaper tabloids are
      suggesting a negative effect on cognition. The underlying research articles address the
      &quot;facial feedback hypothesis&quot;. The hypothesis indicates that expressive behaviour, including
      facial mimic expressions influences the subject's brain via feedback. (Alam 2008) Other
      systemic neurological diseases, e.g of inflammatory origin, may lead to temporary bilateral
      facial nerve palsy (BF). During recovery process, the palsy usually remits completely.

      The effect of bilateral facial muscle palsy on cognition and emotional possessing has never
      been evaluated.

      The results of this pilot study might provide new information about the effect bilateral
      facial palsy on emotional processing and cognition and the facial feedback hypothesis.

      The aim of this controlled pilot study is to assess cognitive function and emotional
      processing in patients with bilateral facial palsy. In addition, differences in cognitive
      function and emotional processing in patients with different manifestations of dystonia
      should be evaluated.

      According to the facial feedback theory, paralysed mimic muscles might alter emotional
      processing. Therefore, investigators compare patients with bilateral facial muscle palsy and
      healthy controls. Investigators expect no influence of facial muscle palsy on cognitive
      functions in any of the tested groups; the investigators expect a mild impairment of
      emotional processing only in the patients group with bilateral facial muscle palsy (BEB and
      BF). In addition, the investigators expect no difference in emotional processing in patients
      with different manifestations of dystonia (BEB and CD) at remission. There might be a slight
      difference of emotional processing in patients with different manifestations of dystonia (BEB
      and CD) at time of prominent facial palsy.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2012</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">May 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>I-S-T-2000R- (intelligence-structure-test 2000R)</measure>
    <time_frame>up to four weeks</time_frame>
    <description>Test to evaluate Intelligence
Subtest &quot;Matrixes&quot;
Subtest &quot;Analogies&quot;</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Beck's depression-inventory-II</measure>
    <time_frame>up to four weeks</time_frame>
    <description>Evaluation of depression (BDI-II; Hautzinger et al., 2009)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Apathy Evaluation Scale</measure>
    <time_frame>up to four weeks</time_frame>
    <description>Evaluation of apathy (AES; Luecken et al., 2006)</description>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Actual">84</enrollment>
  <condition>Intelligence</condition>
  <condition>Emotion</condition>
  <arm_group>
    <arm_group_label>Blepharospasm</arm_group_label>
    <description>Patients suffering from Blepharospasm</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cervical Dystonia</arm_group_label>
    <description>Patients suffering from cervical dystonia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bilateral facial palsy</arm_group_label>
    <description>Patients suffering from bilateral facial palsy of inflammatory origin</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy Control</arm_group_label>
    <description>Control subjects</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Two patient groups with bilateral facial palsy, 31 patients each (group A: BEB, , group C:
        BF), recruited from the Botulinum toxin outpatient's clinic and general outpatient's clinic
        of the Medical University of Vienna. Two control groups, 31 patients with CD, recruited
        from the Botulinum toxin outpatient's clinic of the Medical University of Vienna, and and
        31 age-and education-matched HC, will perform neuropsychological testing of approximately
        60 minutes duration at time of prominent facial palsy (baseline) and at remission (visit
        1). HC age and education matched, will be tested twice.

        A total of 124 persons will be tested. All participants will sign an informed consent form.
        Group A: 31 BEB Group B: 31 CD Group C: 31 BF Group D: 31 HC
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patients:

          -  willing to participate in this pilot trial

          -  bilateral facial palsy

          -  age 18-80 years

        Control:

          -  willing to participate in this pilot trial

          -  age,

          -  gender and

          -  education (duration of school attendance) matched

          -  and/or cervical dystonia

        Exclusion Criteria:

          -  neurological or psychiatric comorbidity

          -  psychotropic drugs
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eduard Auff, Prof., MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Neurology, Medical University of Vienna</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Neurology, Medical University of Vienna</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <reference>
    <citation>Havas DA, Glenberg AM, Gutowski KA, Lucarelli MJ, Davidson RJ. Cosmetic use of botulinum toxin-a affects processing of emotional language. Psychol Sci. 2010 Jul;21(7):895-900. doi: 10.1177/0956797610374742. Epub 2010 Jun 14.</citation>
    <PMID>20548056</PMID>
  </reference>
  <reference>
    <citation>Alam M, Barrett KC, Hodapp RM, Arndt KA. Botulinum toxin and the facial feedback hypothesis: can looking better make you feel happier? J Am Acad Dermatol. 2008 Jun;58(6):1061-72. doi: 10.1016/j.jaad.2007.10.649. Review.</citation>
    <PMID>18485989</PMID>
  </reference>
  <reference>
    <citation>Hennenlotter A, Dresel C, Castrop F, Ceballos-Baumann AO, Wohlschl√§ger AM, Haslinger B. The link between facial feedback and neural activity within central circuitries of emotion--new insights from botulinum toxin-induced denervation of frown muscles. Cereb Cortex. 2009 Mar;19(3):537-42. doi: 10.1093/cercor/bhn104. Epub 2008 Jun 17. Erratum in: Cereb Cortex. 2010 Jan;20(1):253. Baumann, Andres O Ceballos [corrected to Ceballos-Baumann, Andres O].</citation>
    <PMID>18562330</PMID>
  </reference>
  <verification_date>June 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 31, 2012</study_first_submitted>
  <study_first_submitted_qc>June 30, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 1, 2014</study_first_posted>
  <last_update_submitted>June 30, 2014</last_update_submitted>
  <last_update_submitted_qc>June 30, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 1, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Vienna</investigator_affiliation>
    <investigator_full_name>Kirsten Elwischger, MD</investigator_full_name>
    <investigator_title>Dr. Kirsten Elwischger</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Facial Paralysis</mesh_term>
    <mesh_term>Bell Palsy</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

